Logo image of LGVN

LONGEVERON INC-A (LGVN) Stock Price, Quote, News and Overview

NASDAQ:LGVN - Nasdaq - US54303L2034 - Common Stock - Currency: USD

1.56  -0.08 (-4.88%)

After market: 1.6592 +0.1 (+6.36%)

LGVN Quote, Performance and Key Statistics

LONGEVERON INC-A

NASDAQ:LGVN (2/21/2025, 8:00:02 PM)

After market: 1.6592 +0.1 (+6.36%)

1.56

-0.08 (-4.88%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High6.4
52 Week Low0.77
Market Cap23.15M
Shares14.84M
Float12.01M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-07 2025-03-07/amc
IPO02-12 2021-02-12


LGVN short term performance overview.The bars show the price performance of LGVN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

LGVN long term performance overview.The bars show the price performance of LGVN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of LGVN is 1.56 USD. In the past month the price decreased by -8.24%. In the past year, price decreased by -69.88%.

LONGEVERON INC-A / LGVN Daily stock chart

LGVN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.97 357.10B
AMGN AMGEN INC 15.29 162.72B
GILD GILEAD SCIENCES INC 23.85 137.00B
VRTX VERTEX PHARMACEUTICALS INC 1669.79 124.40B
REGN REGENERON PHARMACEUTICALS 15.34 76.56B
ARGX ARGENX SE - ADR N/A 39.16B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.32B
BNTX BIONTECH SE-ADR N/A 28.77B
ONC BEIGENE LTD-ADR N/A 27.25B
NTRA NATERA INC N/A 21.43B
BIIB BIOGEN INC 8.54 20.49B
SMMT SUMMIT THERAPEUTICS INC N/A 16.31B

About LGVN

Company Profile

LGVN logo image Longeveron Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Miami, Florida and currently employs 23 full-time employees. The company went IPO on 2021-02-12. Longeveron Inc. is a clinical-stage biotechnology company. The firm is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The firm's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The firm is primarily focused on three pipeline indications, which include Hypoplastic Left Heart Syndrome (HLHS), Alzheimer’s disease (AD) and Aging-related Frailty. Its Lomecel-B has multiple mechanisms of action encompassing pro-vascular, pro-regenerative, anti- inflammatory, and tissue repair and healing effects with potential applications across a spectrum of disease areas. The firm has bone marrow supply contracts in with two suppliers: the Oklahoma Blood Institute and Vista Health Research.

Company Info

LONGEVERON INC-A

1951 NW 7th Ave, Ste 520

Miami FLORIDA 33136 US

CEO: Geoff Green

Employees: 24

Company Website: https://www.longeveron.com/

Investor Relations: http://investors.longeveron.com/overview/default.aspx

Phone: 13053027158

LONGEVERON INC-A / LGVN FAQ

What is the stock price of LONGEVERON INC-A today?

The current stock price of LGVN is 1.56 USD. The price decreased by -4.88% in the last trading session.


What is the ticker symbol for LONGEVERON INC-A stock?

The exchange symbol of LONGEVERON INC-A is LGVN and it is listed on the Nasdaq exchange.


On which exchange is LGVN stock listed?

LGVN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for LONGEVERON INC-A stock?

9 analysts have analysed LGVN and the average price target is 9.05 USD. This implies a price increase of 480.29% is expected in the next year compared to the current price of 1.56. Check the LONGEVERON INC-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LONGEVERON INC-A worth?

LONGEVERON INC-A (LGVN) has a market capitalization of 23.15M USD. This makes LGVN a Nano Cap stock.


How many employees does LONGEVERON INC-A have?

LONGEVERON INC-A (LGVN) currently has 24 employees.


What are the support and resistance levels for LONGEVERON INC-A (LGVN) stock?

LONGEVERON INC-A (LGVN) has a support level at 1.51 and a resistance level at 1.62. Check the full technical report for a detailed analysis of LGVN support and resistance levels.


Is LONGEVERON INC-A (LGVN) expected to grow?

The Revenue of LONGEVERON INC-A (LGVN) is expected to grow by 165.46% in the next year. Check the estimates tab for more information on the LGVN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LONGEVERON INC-A (LGVN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LONGEVERON INC-A (LGVN) stock pay dividends?

LGVN does not pay a dividend.


When does LONGEVERON INC-A (LGVN) report earnings?

LONGEVERON INC-A (LGVN) will report earnings on 2025-03-07, after the market close.


What is the Price/Earnings (PE) ratio of LONGEVERON INC-A (LGVN)?

LONGEVERON INC-A (LGVN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.28).


What is the Short Interest ratio of LONGEVERON INC-A (LGVN) stock?

The outstanding short interest for LONGEVERON INC-A (LGVN) is 4.88% of its float. Check the ownership tab for more information on the LGVN short interest.


LGVN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

LGVN Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to LGVN. No worries on liquidiy or solvency for LGVN as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LGVN Financial Highlights

Over the last trailing twelve months LGVN reported a non-GAAP Earnings per Share(EPS) of -6.28. The EPS increased by 35.92% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -91.5%
ROE -106.79%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%87.86%
Sales Q2Q%415.33%
EPS 1Y (TTM)35.92%
Revenue 1Y (TTM)141.46%

LGVN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to LGVN. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 65.95% and a revenue growth 165.46% for LGVN


Ownership
Inst Owners2.57%
Ins Owners10.59%
Short Float %4.88%
Short Ratio2.25
Analysts
Analysts82.22
Price Target9.05 (480.13%)
EPS Next Y65.95%
Revenue Next Year165.46%